What this means
This study is still recruiting, so no results are available yet. It aims to learn how gut bacteria and hormone changes relate during menopause.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 40–64
- Where
- 1 site
The science
- Registered title
- AGEWISE: Unravelling the Gut-Hormone Axis in Women's Ageing
- Trial ID
- NCT07614542 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Menopause, Gut Microbiome, Hormonal Changes, Chronic Low-Grade Inflammation, Inflammaging
- Sponsor
- Gulbenkian Institute for Molecular Medicine
- Ages
- 40 Years to 64 Years
- Dates
- First posted May 29, 2026 · updated May 29, 2026
Registry summary
AGEWISE is an observational study that aims to understand how changes in gut microbiome are related to hormonal changes during women's ageing, particularly across the different stages of menopause. The study will include healthy women aged 40 to 64 years living in Portugal, who will provide stool and blood samples and complete questionnaires about their health, lifestyle, diet, and menopausal symptoms. Researchers will study the gut microbiome together with hormone levels and markers of inflammation to better understand how menopause affects long-term health and to support the development of improved prevention strategies for women.
Sites (1)
- Gulbenkian Institute for Molecular Medicine, Lisbon, Lisbon, Portugal